4basebio (4BB.L) traded up 0.95 % during a 24 hours period ending at 05:33 AM Central Europe on Wednesday 28th. One 4basebio stock can currently be bought for about GBX 530 on popular exchanges. Current supply of 4basebio stocks is 15.5 mn. 4basebio has a current market capitalization of GBX 109.8 mn and approximately GBX 1.9 mn worth of 4basebio was traded on exchanges in the last 24 hours. Since last month end, 4basebio has traded -5.78 % down. Simple moving average of last 200 days is at GBX 522.9. The highest price of past 52 weeks was recorded at GBX 820 on 11/10/2025. 52 weeks low was at GBX 420 on 05/19/2026.
Here is how related stocks have performed in the past 24 hours:
Tpximpact (TPX.L) traded up 3.63 % and now trades at GBX 98.5. Current market capitalisation for Tpximpact is GBX 126.9 mn.
H-power (HPOW.L) traded up 3.28 % and now trades at GBX 8.39. Current market capitalisation for H-power is GBX 126.2 mn.
Global Opportunities P (GOT.L) traded down -0.46 % and now trades at GBX 323.5. Current market capitalisation for Global Opportunities P is GBX 126.9 mn. Global Opportunities P has a current price to earnings ratio of 11.91.
Journeo (JNEO.L) traded up 0.18 % and now trades at GBX 543. Current market capitalisation for Journeo is GBX 127.9 mn. Current price/earnings ratio for Journeo is 21.69.
Inspecs (SPEC.L) traded flat 0 % and now trades at GBX 90. Current market capitalisation for Inspecs is GBX 131.4 mn.
About 4basebio
4basebio PLC is a biotech company operating in the Health Care sector, with its base located in Cambridge, United Kingdom. The company specializes in developing gene therapy technologies and solutions, with a particular focus on testing and developing nanoparticles for non-viral delivery of nucleic acids. 4basebio serves customers in the United Kingdom. You can find more information about their activities on their website at www.4basebio.com and they are listed on the London Stock Exchange.